baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ACER GDR REG.S/5 TA 10/ US0044342055 /

2024-06-24 9:33:06 PM	Chg. +0.200	Volume	Bid2024-06-24	Ask2024-06-24	High	Low
7.000EUR	+2.94%	0 Turnover: 0.000	-Bid Size: -	-Ask Size: -	7.000	6.600

TeleTrader 2022-03-31 PC makers cut growth outlook due to Ukraine crisis - report

GlobeNewswire 2020-10-01 Acer Therapeutics to Present at the Virtual BIO Investor Forum Digital

GlobeNewswire 2020-08-25 Acer Therapeutics to Virtually Present at Upcoming Investor Conferences

GlobeNewswire 2020-08-13 Acer Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

GlobeNewswire 2020-07-08 Acer Therapeutics Announces Administration of ACER-001 in a Fasted State Increased Systemic Exposure...

GlobeNewswire 2020-05-14 Acer Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

GlobeNewswire 2020-05-11 Acer Therapeutics to Develop Emetine as Potential COVID-19 Treatment in Collaboration with National ...

GlobeNewswire 2020-04-30 Acer Therapeutics Announces Common Stock Purchase Agreement for up to $15 million with Lincoln Park ...

GlobeNewswire 2020-03-18 Acer Receives Formal Dispute Resolution Request (FDRR) Response from FDA’s Office of New Drugs

GlobeNewswire 2020-03-18 Acer Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate...

GlobeNewswire 2020-02-24 Acer Therapeutics Announces ACER-001 for Urea Cycle Disorders Trial Shows Bioequivalence to BUPHENYL...

GlobeNewswire 2019-12-16 Acer Therapeutics Announces Full Enrollment of Part B in ACER-001 Pivotal Bioavailability and Bioequ...

GlobeNewswire 2019-11-13 Acer Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire 2019-10-28 Acer Therapeutics Announces Full Enrollment of Part A in ACER-001 Pivotal Bioavailability and Bioequ...

GlobeNewswire 2019-08-27 Acer Therapeutics to Present at the 21st Annual H.C. Wainwright Global Investment Conference

GlobeNewswire 2019-08-13 Acer Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire 2019-07-25 Acer Therapeutics to Host Conference Call and Webcast to Discuss Update on its Pipeline Programs

GlobeNewswire 2019-07-05 Acer Therapeutics Announces Restructuring and Update on Pipeline Programs

GlobeNewswire 2019-06-25 Acer Therapeutics Receives Complete Response Letter from U.S. FDA for use of EDSIVO™ (celiprolol) in...

GlobeNewswire 2019-05-31 Acer Therapeutics Announces Poster Presentation at Society for Vascular Medicine Annual Meeting

GlobeNewswire 2019-05-23 Acer Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire 2019-05-14 Acer Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire 2019-05-07 Acer Therapeutics to Present at UBS Global Healthcare Conference

GlobeNewswire 2019-04-16 Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry D...

GlobeNewswire 2019-03-13 CORRECTING and REPLACING -- Acer Therapeutics to Participate in Upcoming Investor Conferences

ACER GDR REG.S/5 TA 10/ US0044342055 /

If you wish to receive reply to your feedback, please provide your email address.